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Abstract
COVID-19 preventions have cut access to routine medical care, especially for many chronic neurological disease patients. This condition has especially pro-
moted telemedicine use in providing healthcare. This study aimed to review telemedicine use catalyzed by several regulations of the Indonesian Government
and review 20 cases from Bethesda Hospital in Yogyakarta providing online consultation services. Perceptions of experience on telemedicine were collected
from neurological patients at the hospital who were asked about their impressions of consultations and pharmacy medication services, and their suggestions
about the new system in outpatient consultations. The regulations for telemedicine use are relevant because of these patients’ risks related to comorbidities
and treatments. Of the 20 respondents involved in this study, 15 (75%) were satisfied with the service, 3 (15%) very satisfied, and 2 (10%) others neutral.
Most respondents suggest improvement of reimbursement (80%) and others suggest improvement on medications (10%) and services (10%). System and
hospital requirements for telemedicine services for neurological cases have been accelerated due to the pandemic. Telemedicine is a way to provide
healthcare needed by patients at high risks for COVID-19 fatality related to comorbidities and treatments. Payment regulations, regulatory structures, state li-
censing, and credentialing across hospitals for better telemedicine experience need to be enhanced.
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Introduction 
In December 2019, a cluster of pneumonia cases
occurred on Wuhan, China. The World Health
Organization (WHO) has officially named the disease as
coronavirus disease 2019 (COVID-19) and it has become
a major health problem worldwide.1,2 Data on May 2,
2020, showed that there were 10,843 positive cases in
Indonesia, with a mortality rate reaching 831 (7.7%)
cases.3 A review study has estimated the basic
reproduction number (R0) of SARS-CoV-2 to be around
2.2.4
Social distancing and quarantine have cut off access
to routine medical care for many chronic neurological
disease patients. Patients with the chronic neurological
disease have some poor prognostic factors for COVID-
19 fatality, for example, advanced age (alzheimer and
parkinson) or vascular risk factors (stroke).5 Data from
Indonesia show that most of the fatal cases have been
related to these risks (hypertension, diabetes, and
cardiovascular / stroke condition).3
The Indonesian Government has already launched the
Regulation on the Health Informatics and Telemedicine
System in 2014.6 With the Indonesian Medical Council
(IMC), or Komisi Kedokteran Indonesia (KKI), they
have also launched another regulation dealing with the
COVID-19 crisis.7,8,9 This regulation states that patients
with high risks should avoid traditional outpatient visits
if possible, especially in crowded hospitals. The current
COVID-19 crisis has accelerated the use of telemedicine
for caring for these patients, especially with many
comorbid and advanced age. This study aimed to review
the acceleration of telemedicine use catalyzed by the
government regulations, as well as to review 20 cases
from Bethesda Hospital in Yogyakarta, Indonesia, which
provides online consultation services.
Method
This study was a cross-sectional study using a
questionnaire-based measurement to evaluate the
satisfaction of telemedicine use during the COVID-19
pandemic. It collects the current regulations of the
Indonesian Government and medical association on
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telemedicine and COVID-19 as shown in Table 1. It also
collects case series from Bethesda Hospital in Yogyakarta
from neurological patients who used telemedicine (video
call by application for outpatient consultation). The
patient survey was undertaken after consents were
obtained following video-call outpatient consultations.
The subjects were asked about their perceptions of the
consultation, the service of medication on pharmacy, and
their suggestions about the new system in outpatient
consultation.10 Their responses were noted in self-made
questionnaires designed for this study. The system and
hospital requirements for telemedicine services for
neurological cases were also reviewed in this study. This
study has obtained ethical permission from the Bethesda
Hospital Research and Development Department. Oral
informed consent had been taken from the subjects
before the survey was conducted. 
Results
As a response to the COVID-19 crisis in Indonesia,
the Indonesian Government has launched the Regulation
of Ministry of Health on the use of telemedicine (Table
1). The Indonesian Neurological Association (INA) also
responded to this situation.11
These regulations are very suitable for patients with
neurological diseases because of these patients’
conditions (advanced age), risk factors (hypertension and
diabetes), and treatments (immunosuppressive for
multiple sclerosis or myasthenia gravis). Most of these
regulations require electronic prescribing and electronic
medical records for the use of telemedicine consultations.
The prescriptions of controlled substances such as
analgesics or opioids require legitimate medical purposes
in accordance with the law. 
Outpatient visits for neurological disease during the
COVID-19 pandemic are inefficient and often unsafe.
Individuals may require long travels to hospitals, wherein
sparsely populated areas it may take hours for them.
Following long commutes, patients often sit in crowded
waiting rooms and pharmacies. This study reviews 20
cases that have already used online consultation and the
demographic data is shown in Table 2. Most of the
subjects are male (70%), > 60 years old (90%) and have
been diagnosed with stroke (60%). More than 75% of
the subjects were satisfied with the use of telemedicine
for their chronic neurological consultation. In terms of
suggestion, 80% of the subjects suggest the reimburse -
ment services be evaluated during the COVID-19
pandemic for their consultations.
Discussion
The COVID-19 pandemic has resulted in
unprecedented disruptions in health care and hospital
services. It has not only been affecting the COVID-19
patients, but also patients with chronic neurological
cases.12,13 The significant impact of the COVID-19
pandemic on the healthcare system and the rapid
depletion of its resources, urgent steps should be taken
while managing acute stroke patients to prevent the
spread of the disease, to protect both patients and staff,
and to minimize the uses of already strained resources. 
The strict emphasis on self-isolation and social
distancing has become the main factor that raises serious
concerns about the well-being of patients with chronic
Table 1. Regulations from the Indonesian Government and Medical Associations
Regulation                                                           Date                        Scope                                                          Requirement
The Ministry of Health (303/2020)                     April 29, 2020         Inpatient and outpatients setting                 Electronic prescribing and electronic
                                                                                                                                                                               medical record
Indonesian Medical Council (IMC), or                April 29, 2020         Non-emergency cases should use                 Electronic prescribing and electronic 
Komisi Kedokteran Indonesia (KKI),                                                  telemedicine                                                medical record
(74/2020)                                                                                            Outpatients setting                                      
The Indonesian Food and Drug Authority           April 2020               Medicine, food supplement, and tradi-        Electronic prescribing and electronic 
(FDA) (8/2020)                                                                                   tional medicine                                            medical record
                                                                                                            Exception: opioid analgesic, tranquilizer     
The Indonesian Neurological Association            April 2020               Mild cases, over the counter medication,    None
(INA) (032/2020)                                                                                symptomatic treatment                                
Table 2. The Characteristics of the 20 Patients Using Online Consultations at
              Bethesda Hospital Neurological Outpatient Clinics on April 2020
Characteristic                     Category                               Total               %
Sex                                      Male                                       14                70%
                                           Female                                      6                30%
Age                                     < 60 years old                           2                10%
                                           > 60 years old                         18                90%
Diagnosis                            Stroke                                     12                60%
                                           Parkinson                                 2                10%
                                           Vertigo                                     2                10%
                                           Back pain                                  1                  5%
                                           Other                                        3                15%
Level of satisfaction            Very satisfied                            3                15%
with the services                 Satisfied                                  15                75%
                                           Neither satisfied or not             2                10%
                                           Not satisfied                             0                     0
                                           Very not satisfied                     0                     0
Suggestions from patients   Reimbursement                      16                80%
                                           Medication                               2                10%
                                           Services                                    2                10%
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neurological diseases, given these patients require routine
hospital visits for evaluation and medical adjustments.14
More than 75% of the subjects in our study were
satisfied with the use of telemedicine for their online
consultations. These results may become a reference for
some hospitals that some patients and caregivers can
cope with the larger use of telemedicine for health care
services. A previous study has already shown the
potential for using telemedicine in disasters and public
health emergencies.15
The rapid responses from the Indonesian Government
and KKI on the potential use of telemedicine have been
responded by professionals and specialty associations.
The regulation cannot be responded to immediately by
every hospital because of the limitations on electronic
medical records and electronic prescribing system. A
previous study has shown that there is great disparity
among health care facilities and hospitals in Indonesia.16
Our study on 20 cases with chronic neurological
disease patients was promising. Most respondents
showed a positive response to the new outpatient
consultation method. Most of our patients are older than
60 years old and disabled due to their illness (stroke).
Therefore, the video calls online consultations were
established by the providers to avoid travel to in-person
care sites. This study only focused on doctor-patient
consultation. In stroke care, much additional care should
be in place. The majority of the important works done by
dietary consultants, pharmacists, and stroke education
nurses could potentially be done without direct patient
contact in many cases. The challenges will be in the
physical therapy and rehabilitation aspects.13
Most of our subjects (80%) suggested the re -
imbursement method be recalculated because of the
differences between direct consultation and telemedicine
in terms of physical examination and communication. A
past study of telemedicine and reimbursement for
vascular surgery consultation was significant to the
patients. The use of telemedicine provided an increase in
reimbursement from private payers and acceptance from
patients, which ranged from 0% to 67% of the total
charges billed. However, telemedicine use has proven to
be effective to reach a broader population base, and
without significant cost to the patients.17
The use of telemedicine, especially online
consultation, has been growing very slowly in Indonesia.
Face to face consultations has become the main method
of outpatient visits. This study shows that the system,
hospital system, and regulations have been accelerated
due to the COVID-19 pandemic. For the neurological
disease patients, these conditions are relevant because of
their risks related to the comorbidities and treatments.
The American Academy of Neurology describes the
limitations of telemedicine especially in the terms of
neurological examination including comprehensive eye
exams, neuromuscular components, and vestibular
examinations.17 The main barriers to maintaining this
telemedicine are related to the reimbursement system.
This approach can only be conducted in private patients
and limited for patients managed under the national
health insurance program. The payers for the national
health insurance system and other private insurances
company should modify their payment policy in response
to COVID-19. The limitations of our study are that there
are no follow-ups for the long term and clinical
outcomes, as well as the measurement methods of the
subjects’ satisfaction, which are based on self-made
questionnaires. Therefore, the validity and reliability of
the instrument have yet to be tested. 
Conclusion
The COVID-19 pandemic has presented unique
challenges to hospital and patients care. The significant
impact of the pandemic on the healthcare system in
Indonesia has called for urgent steps for managing
chronic neurological patients. The use of telemedicine is
required to prevent the spread of the disease, protect
both patients and staff, and minimize the uses of already
strained resources. Payment and regulatory structures,
state licensing, credentialing across hospitals should be
modified as the response to this.
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